{"id":60802,"date":"2024-02-28T07:09:25","date_gmt":"2024-02-28T07:09:25","guid":{"rendered":"https:\/\/medsname.com\/unicontin-e\/"},"modified":"2026-04-30T10:23:42","modified_gmt":"2026-04-30T10:23:42","slug":"unicontin-e","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/unicontin-e\/","title":{"rendered":"Unicontin-E"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 28px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 10px 0;font-size:18px;color:#1a1a1a;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Unicontin-E?<\/h3>\n<p><strong>Unicontin-E<\/strong> con\u021bine <strong>teofilin\u0103<\/strong>, un <strong>bronhodilatator metilxantinic<\/strong> cu efecte antiinflamatoare, utilizat ca terapie adjunct\u0103 \u00een astmul cronic \u0219i BPOC. Teofilina ac\u021bioneaz\u0103 pe mai multe \u021binte \u2014 inhibarea fosfodiesterazei (cre\u0219terea cAMP), antagonismul receptorilor de adenozin\u0103 \u0219i activarea HDAC2 (antiinflamator). Are un <strong>indice terapeutic \u00eengust<\/strong> (\u021bint\u0103 seric\u0103 10\u201320 mg\/L; toxicitate la peste 20) \u0219i numeroase interac\u021biuni medicamentoase, necesit\u00e2nd dozare atent\u0103 \u0219i (la unii pacien\u021bi) monitorizarea nivelului sanguin. Fiecare tablet\u0103 cu eliberare controlat\u0103 con\u021bine <strong>400 mg<\/strong>, fabricat\u0103 de <strong>Modi-Mundipharma<\/strong> \u00een fabrici certificate WHO-GMP.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #e0e0e0;padding:12px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesator Verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare Worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<h2>Ce este Unicontin-E?<\/h2>\n<p>Unicontin-E este un bronhodilatator oral metilxantinic. Metilxantinele sunt derivate din alcaloizi naturali (teofilina este dimetilxantina prezent\u0103 \u00een ceai). Utilizarea lor a sc\u0103zut din anii 1990, pe m\u0103sur\u0103 ce agonii \u03b22 inhala\u021bi \u0219i corticosteroidii au devenit tratamente de prim\u0103 linie \u2014 dar ele \u00ee\u0219i p\u0103streaz\u0103 rolul ca terapie adjunctiv\u0103 de a treia linie \u00een astmul sever \u0219i BPOC.<\/p>\n<h2>Cum func\u021bioneaz\u0103 Unicontin-E?<\/h2>\n<ul>\n<li><strong>Inhibarea fosfodiesterazei (PDE3, PDE4)<\/strong> \u2014 cre\u0219te nivelul de AMP ciclic \u00een mu\u0219chii netezi ai c\u0103ilor respiratorii \u0219i \u00een celulele inflamatorii; rezultatul net este bronhodilata\u021bia \u0219i reducerea eliber\u0103rii de mediatorii.<\/li>\n<li><strong>Antagonismul receptorilor de adenozin\u0103<\/strong> \u2014 blocheaz\u0103 bronhoconstric\u021bia mediat\u0103 de adenozin\u0103 \u0219i eliberarea de mediatorii din celulele mast.<\/li>\n<li><strong>Activarea HDAC2<\/strong> (teofilina la niveluri serice sc\u0103zute 5\u201310 mg\/L) \u2014 restabile\u0219te r\u0103spunsul la corticosteroizi \u00een BPOC \u0219i astmul sever, unde rezisten\u021ba la steroizi este par\u021bial mediat\u0103 de sc\u0103derea HDAC2.<\/li>\n<li><strong>Contractilitatea diafragmatic\u0103<\/strong> \u2014 metilxantinele reduc oboseala diafragmatic\u0103, utile \u00een BPOC cu limitare sever\u0103 a fluxului de aer.<\/li>\n<\/ul>\n<h2>Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Astm cronic sever<\/strong> \u2014 ad\u0103ugare la terapie cu doze mari de ICS-LABA acolo unde este necesar\u0103 bronhodilata\u021bie suplimentar\u0103<\/li>\n<li><strong>Men\u021binerea BPOC<\/strong> \u2014 ad\u0103ugare la terapie cu LAMA-LABA sau terapie tripl\u0103<\/li>\n<li><strong>Astm nocturn<\/strong> \u2014 forma de eliberare prelungit\u0103 asigur\u0103 bronhodilata\u021bie pe timpul nop\u021bii<\/li>\n<li><strong>Apnee la prematuri<\/strong> (teofilin\u0103) \u2014 utilizare neonatal\u0103<\/li>\n<li><strong>Cor pulmonale \u0219i hipertensiune pulmonar\u0103<\/strong> \u2014 adjunct<\/li>\n<\/ul>\n<h2>Doza Unicontin-E<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Pacient<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Doza<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Frecven\u021b\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Adul\u021bi \u2014 ini\u021bial<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>200 mg<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">De dou\u0103 ori pe zi; titra\u021bi p\u00e2n\u0103 la nivelul seric de 10\u201320 mg\/L<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Adul\u021bi \u2014 \u00eentre\u021binere<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>400 mg<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">De dou\u0103 ori pe zi (sau 600 mg o dat\u0103 pe zi ER)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">V\u00e2rstnici \/ insuficien\u021b\u0103 cardiac\u0103 \/ afec\u021biuni hepatice<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u00cenjum\u0103t\u0103\u021bi\u021bi doza<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi nivelul seric<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Efecte secundare ale Unicontin-E<\/h2>\n<ul>\n<li>Grea\u021b\u0103, v\u0103rs\u0103turi, dispepsie<\/li>\n<li>Dureri de cap<\/li>\n<li>Tremur<\/li>\n<li>Insomnie, agita\u021bie<\/li>\n<li>Tahicardie, palpita\u021bii<\/li>\n<li>Hipokaliemie u\u0219oar\u0103 la doze mari<\/li>\n<\/ul>\n<p><strong>Niveluri toxice (&gt;20 mg\/L) \u2014 urgen\u021b\u0103:<\/strong><\/p>\n<ul>\n<li>Grea\u021b\u0103 sever\u0103, v\u0103rs\u0103turi persistente<\/li>\n<li>Aritmie cardiac\u0103 (fibrila\u021bie atrial\u0103, tahicardie supraventricular\u0103)<\/li>\n<li>Criz\u0103 epileptic\u0103 (adesea f\u0103r\u0103 avertisment)<\/li>\n<li>Hipotensiune, hiperglicemie, hipokaliemie, hipercalcemie<\/li>\n<\/ul>\n<h2>Avertismente \u0219i precau\u021bii<\/h2>\n<ul>\n<li><strong>Indice terapeutic \u00eengust.<\/strong> Nivelul \u021bint\u0103 \u00een ser: 10\u201320 mg\/L. Verifica\u021bi concentra\u021bia sanguin\u0103 la 5 zile dup\u0103 \u00eenceperea tratamentului, dup\u0103 modificarea dozei, la introducerea unui nou medicament interactiv, dup\u0103 renun\u021barea la fumat \u0219i \u00een timpul bolii\/febrei (clearance-ul scade).<\/li>\n<li><strong>Multe interac\u021biuni medicamentoase<\/strong> \u2014 consulta\u021bi tabelul de interac\u021biuni. Majoritatea sunt metabolizate de CYP1A2; numero\u0219i inhibitori \u0219i inductori modific\u0103 semnificativ nivelurile.<\/li>\n<li><strong>Fumatul<\/strong> induce CYP1A2 \u0219i reduce nivelurile de teofilin\u0103 cu ~50% \u2014 retitra\u021bi la \u00eencetarea fumatului.<\/li>\n<li><strong>Boal\u0103 cardiac\u0103:<\/strong> utiliza\u021bi cu precau\u021bie \u00een aritmii, insuficien\u021b\u0103 cardiac\u0103, hipertensiune sever\u0103.<\/li>\n<li><strong>Hipertiroidism:<\/strong> clearance crescut plus efecte adrenergice exagerate.<\/li>\n<li><strong>Sarcin\u0103 \u0219i al\u0103ptare:<\/strong> de obicei evitat; utiliza\u021bi doar dac\u0103 beneficiul este clar.<\/li>\n<li><strong>Boal\u0103 hepatic\u0103:<\/strong> reduce\u021bi doza \u2014 metilxantinele sunt metabolizate hepatic.<\/li>\n<\/ul>\n<h2>Contraindica\u021bii<\/h2>\n<ul>\n<li>Hipersensibilitate la teofilin\u0103 sau alte xantine (cafein\u0103, teobromin\u0103)<\/li>\n<li>Boal\u0103 ulceroas\u0103 peptic\u0103 activ\u0103<\/li>\n<li>Tahiartmii necontrolate<\/li>\n<li>Insuficien\u021b\u0103 cardiac\u0103 sever\u0103 (NYHA IV)<\/li>\n<\/ul>\n<h2>Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Medicament interactiv<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ciprofloxacin\u0103, eritromicin\u0103, claritromicin\u0103, fluvoxamin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inhib\u0103 CYP1A2 \u2192 cre\u0219te nivelul teofilinei \u2192 toxicitate (grea\u021b\u0103, aritmii, convulsii)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi sau reduce\u021bi doza de teofilin\u0103 cu 50%; verifica\u021bi nivelul seric<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Cimetidin\u0103, alopurinol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cre\u0219te nivelul teofilinei<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce\u021bi doza; monitoriza\u021bi nivelurile<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Fenitoin\u0103, carbamazepin\u0103, rifampicin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Induc CYP \u2014 niveluri mai sc\u0103zute<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Poate fi necesar\u0103 o doz\u0103 mai mare<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Fumatul<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Induce CYP1A2 \u2014 niveluri mai sc\u0103zute<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Re-titra\u021bi doza la renun\u021barea la fumat<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u03b2-agoni\u0219ti, diuretice<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hipokaliemie aditiv\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitorizare potasiu<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Depozitare<\/h2>\n<ul>\n<li>Depozita\u021bi la temperaturi sub <strong>25\u00b0C<\/strong> \u00eentr-un loc r\u0103coros \u0219i uscat, departe de lumina direct\u0103 a soarelui.<\/li>\n<li>P\u0103stra\u021bi \u00een ambalajul original p\u00e2n\u0103 la utilizare pentru a proteja de umiditate \u0219i lumin\u0103.<\/li>\n<li>Nu utiliza\u021bi dup\u0103 data de expirare tip\u0103rit\u0103 pe blister.<\/li>\n<li>P\u0103stra\u021bi la distan\u021b\u0103 de copii.<\/li>\n<\/ul>\n<h2>Alternative conexe pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/asthalin-inhaler\/\"><strong>Asthalin Inhaler \u2014 salbutamol pentru ameliorarea simptomelor<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/budecort-inhaler\/\"><strong>Budecort Inhaler \u2014 budesonide ICS pentru preven\u021bie<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/foracort-inhaler\/\"><strong>Inhalator Foracort \u2014 budesonid\u0103 + formoterol ICS-LABA<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tiova-inhaler\/\"><strong>Tiova Inhaler \u2014 tiotropium LAMA pentru BPOC<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/montair\/\"><strong>Montair \u2014 comprimat montelukast LTRA<\/strong><\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>Este teofilina \u00eenc\u0103 utilizat\u0103 \u00een managementul modern al astmului?<\/h3>\n<p>Da, dar ca terapie adjunctiv\u0103 de a treia linie. Agoni\u0219tii \u03b22 inhala\u021bi, ICS, ICS-LABA, LTRA \u0219i LAMA sunt tratamente de prim\u0103 linie; teofilina este ad\u0103ugat\u0103 \u00een cazuri refractare, \u00een special \u00een astmul nocturn. Indicele terapeutic \u00eengust \u0219i numeroasele interac\u021biuni medicamentoase \u00eei limiteaz\u0103 utilizarea.<\/p>\n<h3>Cum se decide doza?<\/h3>\n<p>Ajustat\u0103 la nivelul seric de teofilin\u0103 de 10\u201320 mg\/L. Verifica\u021bi la 5 zile dup\u0103 \u00eenceperea tratamentului, dup\u0103 modificarea dozei, la introducerea unui nou medicament interactiv, la renun\u021barea la fumat \u0219i \u00een timpul bolii\/febrei.<\/p>\n<h3>De ce at\u00e2t de multe interac\u021biuni?<\/h3>\n<p>Teofilina este metabolizat\u0103 de CYP1A2 \u2014 multe medicamente cresc nivelul (ciprofloxacina, eritromicina, fluvoxamina, cimetidina) sau scad nivelul (rifampicina, fenitoina, fumatul).<\/p>\n<h3>C\u00e2t dureaz\u0103 efectul Unicontin-E?<\/h3>\n<p>Comprimatul cu eliberare controlat\u0103 asigur\u0103 acoperire timp de 12 ore. Dozarea de dou\u0103 ori pe zi men\u021bine niveluri serice stabile.<\/p>\n<h3>Care sunt simptomele de toxicitate?<\/h3>\n<p>Grea\u021b\u0103 sever\u0103, v\u0103rs\u0103turi persistente, tahicardie, palpita\u021bii, tremur, hiperactivitate, convulsii (adesea f\u0103r\u0103 avertisment), aritmii, hipotensiune. Toxicitatea peste 20 mg\/L reprezint\u0103 o urgen\u021b\u0103 \u2014 \u00eentrerupe\u021bi doza, verifica\u021bi nivelul, asigura\u021bi \u00eengrijiri de sus\u021binere.<\/p>\n<h3>Pot s\u0103 o iau cu cafea?<\/h3>\n<p>Cafeina \u0219i teofilina sunt ambele metilxantine cu efecte suprapuse. Consumul excesiv de cafein\u0103 poate amplifica tremurul, tahicardia \u0219i insomniile. Reduce\u021bi consumul de cafein\u0103 dac\u0103 apar simptome.<\/p>\n<h3>De ce afecteaz\u0103 fumatul doza?<\/h3>\n<p>Fumatul induce CYP1A2 (enzima care metabolizeaz\u0103 teofilina). Fum\u0103torii au nevoie de doze mai mari; la \u00eentreruperea fumatului, nivelurile cresc \u2014 retitra\u021bi doza.<\/p>\n<h3>Este Unicontin-E sigur \u00een timpul sarcinii?<\/h3>\n<p>De obicei evitat, cu excep\u021bia cazului \u00een care beneficiile sunt clare. Terapia inhalatorie este preferat\u0103.<\/p>\n<h3>Pot zdrobi sau \u00eemp\u0103r\u021bi comprimatele Unicontin-E?<\/h3>\n<p>Nu \u2014 comprimatele cu eliberare controlat\u0103 trebuie \u00eenghi\u021bite \u00eentregi. Zdrobirea distruge matricea de eliberare \u0219i risc\u0103 toxicitate acut\u0103.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Avertizare medical\u0103:<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical profesionist. Consult\u0103 \u00eentotdeauna un profesionist calificat \u00een s\u0103n\u0103tate \u00eenainte de a \u00eencepe, \u00eentrerupe sau schimba orice inhalator sau medicament respirator, mai ales dac\u0103 ai alte afec\u021biuni medicale, iei alte re\u021bete, e\u0219ti gravid\u0103 sau al\u0103ptezi, sau ai peste 65 de ani.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/topme-xl\/\">Topme XL<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">Amifru<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/unibrom-eye-drops\/\">Unibrom Pic\u0103turi Oculare<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/nise-gel\/\">Nise Gel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dynapar\/\">Dynapar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Amelioreaz\u0103 bronhospasmul<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te func\u021bia pulmonar\u0103<br \/>\n\u2705 Reduce dificult\u0103\u021bile de respira\u021bie<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te fluxul aerian<br \/>\n\u2705 Gestioneaz\u0103 simptomele astmatice<\/p>\n<p>Unicontin-E con\u021bine teofilin\u0103.<\/p>","protected":false},"featured_media":60803,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3681,3141,3223],"product_tag":[3731,4926],"class_list":{"0":"post-60802","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-asthma-copd-treatment","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-theophylline","10":"product_tag-unicontin-e","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/60803"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60802"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60802"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60802"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}